Stonnington Group, LLC Novavax Inc Transaction History

Stonnington Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$69.73 - $142.9 $402,690 - $825,247	-5,775 Closed	0 $0
Q4 2021 Jan 12, 2022	BUY	$134.56 - $217.97 $589,372 - $954,708	4,380 Added 313.98%	5,775 $755,000
Q3 2021 Oct 12, 2021	SELL	$177.8 - $270.58 $60,629 - $92,267	-341 Reduced 19.64%	1,395 $229,000
Q2 2021 Jul 09, 2021	BUY	$121.0 - $257.67 $210,056 - $447,315	1,736 New	1,736 $329,000

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.04B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonnington Group, LLC with notifications on news.